Nymox Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2018
March 29, 2019 at 05:21 pm EDT
Nymox Pharmaceutical Corporation announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was USD 299,000 compared to USD 224,000 a year ago. Operating loss was USD 10.641 million compared to USD 13.235 million a year ago. Net loss was USD 10.594 million compared to USD 13.429 million a year ago. Basic loss per share was USD 0.18 compared to USD 0.26 a year ago.